|
Volumn 20, Issue 10, 2006, Pages 1653-1654
|
Reduced-intensity conditioning allogeneic stem cell transplantation: Hype, reality or time for a rethink?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIFUNGAL AGENT;
ANTINEOPLASTIC AGENT;
BUSULFAN;
CYCLOSPORIN A;
IMMUNOMODULATING AGENT;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
THYMOCYTE ANTIBODY;
ACUTE GRAFT VERSUS HOST DISEASE;
ACUTE GRANULOCYTIC LEUKEMIA;
ADOPTIVE IMMUNOTHERAPY;
ALLOGENEIC STEM CELL TRANSPLANTATION;
CANCER SURVIVAL;
CHRONIC GRAFT VERSUS HOST DISEASE;
DISEASE FREE SURVIVAL;
EDITORIAL;
GRAFT VERSUS LEUKEMIA EFFECT;
HEMATOLOGIC MALIGNANCY;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION;
LYMPHOMA;
MALIGNANT NEOPLASTIC DISEASE;
MYCOSIS;
MYELODYSPLASTIC SYNDROME;
MYELOMA;
NONMYELOABLATIVE CONDITIONING;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REDUCED INTENSITY CONDITIONING;
WHOLE BODY RADIATION;
|
EID: 33750077277
PISSN: 08876924
EISSN: 14765551
Source Type: Journal
DOI: 10.1038/sj.leu.2404336 Document Type: Editorial |
Times cited : (9)
|
References (0)
|